"The other area that many conference call attendees will be keenly interested in is the status of the two remaining clinical trials. Enrollment for both is supposed to be complete by June and concluded by year-end.

The company intends to complete AFREZZA's resubmission by mid-2013. This means that regulatory clearance should be granted in early to mid-2014."

Six months to prepare for resubmission and six months to a year for approval?C'mon,let's be real.